Chris@NNW, Author at NetworkNewsWire

FridayAug 08, 2025 10:30 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Secures Financing Advisors, Expands Offerings to Fund Beacon Gold Mill Restart

LaFleur Minerals has engaged FMI Securities and FM Global Markets to raise up to C$5 million in debt financing. The capital will be used to restart production at their fully permitted Beacon Gold Mill in Val-d'Or, Québec. The company also launched two equity offerings: a LIFE private placement and a charity flow-through unit offering, which together could raise over C$5.4 million in additional capital. LaFleur's strategy focuses on near-term production at its Beacon Gold Mill, sourcing material from the Swanson Gold Deposit and other surrounding projects, highlighted by current gold prices and production-ready infrastructure as key advantages. LaFleur Minerals (CSE:…

FridayAug 08, 2025 9:45 am

ONAR Holding Corp. (ONAR) Expands AI Capabilities Through IQSTEL Partnership to Launch Multiagentic Infrastructure

Interconnected network of AI agents fundamentally transforms how marketing agencies create value and scale their impact The infrastructure will be introduced in three key phases: operational streamlining, strategic enablement and creative augmentation ONAR’s sees collaboration as foundational to the company’s long-term vision of building an advanced AI-powered agency system ONAR Holding Corp. (OTCQB: ONAR), a marketing technology company focused on AI-powered growth solutions, has announced the expansion of its strategic partnership with IQSTEL Inc. (NASDAQ: IQST) and IQSTEL’s artificial intelligence subsidiary, Reality Border (https://nnw.fm/ricj7). The collaboration will lead to the development and phased rollout of a multiagentic operating infrastructure designed…

FridayAug 08, 2025 9:00 am

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF): The Cancer Detection Revolution That Could Make Breast Cancer Deaths Preventable

Izotropic's IzoView Breast CT Imaging System represents a breakthrough in dedicated breast imaging technology, addressing persistent limitations in conventional screening methods through proprietary hardware and software FDA regulatory pathway alignment clears the path for a pivotal U.S. clinical study, with the company completing a comprehensive 150-page strategic business plan and advanced financial modeling for commercialization Strategic awareness initiatives including dedicated breastct.com platform and podcast series position the company for market education as breast CT technology emerges as the next generation of cancer detection The medical community stands at the threshold of what could become the most significant advancement in cancer…

ThursdayAug 07, 2025 11:15 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Launches Diamond Drilling at Swanson Project, Beacon Gold Mill Valuation Is Finalized

LaFleur Minerals has begun a fully funded, 5,000-metre diamond drilling campaign at its Swanson Gold Project in Quebec. All required drilling permits have been received, including Forestry Intervention and Authorization to Intervene. Independent valuation pegs Beacon Gold Mill’s replacement cost at over C$71.5 million; Mill rehabilitation and commissioning estimated at C$4.1 million, presenting a low-cost path to near-term production. The company has expanded its land package to over 18,300 hectares, reinforcing its district-scale potential. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0), a Canadian near-term gold producer, has initiated diamond drilling at its Swanson Gold Project in the prolific Abitibi…

ThursdayAug 07, 2025 10:30 am

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Advancing Next-Gen Breast Cancer Imaging

Breast cancer continues to be the most commonly diagnosed cancer among U.S. women, excluding nonmelanoma skin cancer Izotropic is preparing to revolutionize breast cancer imaging with its flagship IzoView Breast CT Imaging System In anticipation of future commercialization, Izotropic is initiating a strategic awareness and engagement campaign Accurate detection and diagnosis remain critical challenges in the fight against breast cancer, especially for women with dense breast tissue where mammography falls short. Izotropic (CSE: IZO) (OTCQB: IZOZF) is at the forefront of addressing these gaps through its IzoView Breast CT Imaging System, a contrast-enhanced CT platform designed for enhanced screening precision.…

ThursdayAug 07, 2025 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS): 27% of Surveyed Business Leaders Expect $5M+ ROI from Quantum Optimization Within First Year

Survey by Wakefield Research and D-Wave shows 46% of surveyed business leaders expect $1 million to $5 million ROI from quantum optimization within the first year of adoption. 81% believe they have reached the limits of classical computing’s capabilities for optimization. 53% are planning to integrate quantum computing into their workflows, while 27% are considering it. Quantum optimization is seen as especially valuable in logistics, supply chain, manufacturing, planning and inventory, and R&D. 88% of participants said their organizations would “go above and beyond” for even a 5% improvement in optimization. A new survey released by D-Wave Quantum Inc. (NYSE:…

ThursdayAug 07, 2025 9:00 am

Lantern Pharma Inc. (NASDAQ: LTRN) Completes Japanese Enrollment for LP-300 Phase 2 HARMONIC(TM) Trial Ahead of Schedule

The trial targets never-smoker non-small cell lung cancer (“NSCLC”) patients, a group with limited treatment options. Japan’s high incidence of never-smoker NSCLC makes it a strategic region for the trial. LP-300 is being tested alongside standard chemotherapy agents in patients who have relapsed after tyrosine kinase inhibitor therapy. Lantern's AI-driven approach may help identify and accelerate development of therapies in underserved cancer markets. Additional trial data from Taiwan and the U.S. is expected later in Q3 2025. Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, has completed targeted patient…

WednesdayAug 06, 2025 12:10 pm

Lantern Pharma Inc. (NASDAQ: LTRN) Launches AI Tool to Predict Efficacy of Cancer Drug Combinations

Lantern Pharma has introduced an AI-powered module within its RADR(R) platform to assess DDA-DDRi combination therapies. The module uses genomic, transcriptomic, and clinical data, to predict treatment synergy and patient response, and supported the design of Lantern’s FDA-cleared Phase 1B/2 trial in triple-negative breast cancer. A review of 221 clinical trials informed the development of the predictive algorithm. Non-PARP DDRi combinations with DNA-damaging agents showed strong outcomes in specific cancer subtypes. Lantern is evaluating licensing opportunities to commercialize the module for broader oncology use. Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine…

WednesdayAug 06, 2025 11:30 am

HeartBeam Inc. (NASDAQ: BEAT) FDA-Cleared System Provides Momentum as Company Moves to Innovate Cardiac Care

The FDA-cleared HeartBeam system enables patients and physicians to access significant arrhythmia data outside traditional clinical settings. The HeartBeam system, credit card–sized and fully portable, represents a breakthrough in ambulatory cardiac care. Beyond ambulatory arrhythmia assessment, the platform is poised for future advancements, including synthesized 12-lead ECG generation. Foundational clearance from the U.S. Food and Drug Administration (“FDA”) for its patented HeartBeam system has proved pivotal for HeartBeam (NASDAQ: BEAT), a cardiac technology company focused on transforming the cardiac-care space (https://nnw.fm/OoaLP). The first cable-free, high-fidelity ECG device that captures the heart’s electrical activity from three distinct directions, the HeartBeam system…

WednesdayAug 06, 2025 10:10 am

Bollinger Innovations Inc. (NASDAQ: BINI) Drives Commercial EV Leadership with Bold Rebrand, Market Clarity

Mullen Automotive recently brought all of its EV products and brands together under one strong and unified identity — Bollinger Innovations. The pivot to one commercial EV brand comes amid mounting demand for electrification in delivery, logistics and municipal vehicle fleets. The company’s new identity is also trading under new Nasdaq stock symbol NASDAQ: BINI. The company’s move under one brand clarifies market positioning, creating cohesion across product lines ready to service the commercial vehicle industry. Bollinger Innovations (NASDAQ: BINI), formerly known as Mullen Automotive, has completed a major corporate transformation, officially rebranding and switching its NASDAQ ticker from MULN to…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Author: Chris@NNW